Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.

NCT00300924 is registered in ClinicalTrials.gov with Diamond Headache Clinic as lead sponsor.

NCT NCT00300924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00300924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.
Lead sponsor
Diamond Headache Clinic
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2007
Enrollment
200
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

migraine